Novo Nordisk’s Wegovy Shows Benefits Beyond Weight Loss
Wall Street Journal
The effectiveness of Novo Nordisk’s blockbuster obesity treatment Wegovy in reducing heart attacks and strokes could be due to more than weight loss alone, according to new clinical trial data.